Rhaeos was founded in 2018 to address a critical
unmet need in the care of patients with
hydrocephalus. Arising from a collaboration
between materials scientists and neurological
surgeons at Northwestern University, we have
developed a noninvasive thermal sensor for
use in the monitoring of ventricular shunt
function. In this manner, we hope to
eradicate the uncertainty faced by patients, families
and healthcare providers alike.
Investigational use only. Products have not been approved by the FDA.
Rhaeos, Inc. 2019